People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Triopsy Medical, Inc. | — | Healthtech | Seed | $4.1M | $571K | 2022 |
David Crawford, MD at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Crawford, MD on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brad Buscher | 1 | 4 |
| John Harper | 1 | 3 |
| Richard Larson | 1 | 3 |
| Nelson Stone | 1 | 3 |
| James Lousararian | 1 | 3 |
| Todd Anderson | 1 | 2 |
| William Kozitza | 1 | 1 |
| John Litchtenegger | 1 | 1 |
| Brad David Buscher | 1 | 1 |
| E. David Crawford | 1 | 1 |
| David Bostwick | 1 | 1 |
| Deborah Wittman | 1 | 1 |
| Michael Montag | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.